A Day After Pfizer, Serum Institute Files for Emergency Use Nod for Covishield
Madhukar Sharma Monday 7th of December 2020 12:28 PM
(0) (0)
The phase-three clinical trial of the Oxford COVID-19 vaccine, Covishield, is being conducted by the Pune-based Serum Institute of India.
Read more: THEWIRE.IN
Leave Your Response